The intriguing co-existence of a chronic periaortitis, a pericarditis and a pancreatitis: case report by Rebelo, M et al.
órgão of ic ial da soc iedade portuguesa de reumatologia - acta reumatol port. 2010;35:160-166
160
c a s o c l í n i c o
t h e i n t r i g u i n g c o - e x i s t e n c e o f a
c h r o n i c p e r i a o r t i t i s ,  a p e r i c a r d i t i s
a n d a p a n c r e at i t i s :  c a s e r e p o r t
Marta Rebelo*, Jandira Lima*, Leonor Ramos*, José Diniz Vieira*, 
Lina Carvalho**, Correia Xavier***, José Nascimento Costa****
Keywords: Chronic periaortitis; Retroperitoneal 
Fibrosis; Vasculitis; Pericarditis; Autoimmune Pan-
creatitis.
Introduction
Chronic periaortitis (CP) is an uncommon disease
characterised by the presence of a fibro-inflam-
matory mass surrounding large-vessels like aorta
and the iliac arteries and extending into the
retroperitoneum, in which often entraps some of
the surrounding structures, like the ureters and in-
ferior vena cava1,2. CP includes a spectrum of idio-
pathic diseases: idiopathic retroperitoneal fibrosis
(IRF), inflammatory aneurysms of the abdominal
aorta and perianeurysmal retroperitoneal fibro-
sis2,3. However, the most accepted definition is the
classification of CP in two forms: the aneurysmal
form (dilated aorta) and the non-aneurysmal one. 
Regarding the pathogenesis of CP, there is no
unified concept. Initially, the leading theory was
that CP was a localized inflammatory reaction
against antigens in the atherosclerotic plaques of
the aorta3,4. However, some recent studies have
demonstrated a strong association between CP and
HLA-DRB1*03, which is a marker of auto-immuni-
ty, being linked to prototypical autoimmune con-
ditions such as type 1 diabetes, myasthenia gravis
and auto-immune thyroiditis5.
Some similarities can also be found in CP and a
number of chronic inflammatory/autoimmune
conditions that diffusely affect the aorta and its
branches and are generically referred as aortitis6,7.
Finally, the hypothesis that some cases of CP (par-
ticularly the non-aneurysmal forms) are part of a
newly recognized clinic-pathological systemic di -
sease, called IgG4-related systemic disease (IGG4-
-RSD), is sustained by recent works6,8. IgG4-RSD is
characterized by increased serum IgG4 concentra-
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tions and IgG4-expressing plasma cells diffusely
infiltrating organs throughout the body8,9,10.  
CP is characterized by non-specific signs and
symptoms related to the mechanic and compres-
sive effects of the retroperitoneal mass on the ad-
jacent structures, such as  back or abdominal pain,
normally described as insidious, persistent and
dull, constipation, deep vein thrombosis, leg ede-
ma, varicocele or hydrocele2,11,12-14.
Constitutional symptoms such as fever and
weight loss may occur in the early stages. Labora-
tory investigation often shows increased acute-
phase reactants, accompanied by normocytic
anaemia, leukocytosis and hypoalbuminaemia2.
Autoantibodies  (particularly antinuclear antibo -
dies) are positive in a varying proportion of the
cases, but with no clinical correlation. The posi-
tivity of anti-neutrophil cytoplasmic antibodies,
rheumatoid factor and antibodies against smooth
muscle cells and thyroglobulin may indicate an as-
sociated auto-immune disorder 2,15,16. 
Because the presentation symptoms are often
non-specific, in the presence of CP and retroperi-
toneal fibrosis, secondary causes such as drugs,
infections and malignancies should be first ex-
cluded17-19.
The “gold-standard” imaging techniques used in
the diagnosis and characterization of CP are: con-
trast-enhanced computed tomography (CT) scan-
ning and magnetic resonance imaging (MRI)18-21. In
the last years the 18F-fluorodeoxyglucose positron
emission tomography (FDG-PET) has been used
for assessing the metabolic activity of the periaor-
tic inflammatory tissue18. 
The histology of the inflammatory periaortic tis-
sue normally shows fibrosis with signs of active
mononuclear cell inflammation6,17. This inflam-
matory infiltrate mainly consist of T and B lympho -
cytes, plasma cells and macrophages, although
scattered eosinophils can also be found inters -
persed between collagen bundles and sclerosis.
The initial clinical approach to these patients
should rule out all the potential factors (i.e.: drugs,
infections) that may exacerbate this disease.
Steroids are considered the first choice option in
medical treatment. The initial dose is 1mg/Kg/day
and treatment decisions related to the degree of
dose reduction must be individualized and based
on clinical and radiological response. Besides
steroids there are some immunosuppressive drugs,
for instance methrotexate, azathioprine, cy-
clophosphamide, mycophenolate mofetil that
have been used as steroid sparing agents or in
those ca ses not responding the initial steroid treat-
ment9,19,22-24. Other drugs with different mecha-
nisms of action, such as tamoxifen23 and
colchicine24 have been used as adjuvant in steroid
treatment cases.
Long-term follow-up is recommended in all pa-
tients and given to the array of therapeutic agents
available it’s possible a therapeutic approach ca-
pable of controlling the disease course that allows
a sustained long-lasting remission.
Case report
The authors report the case of a 71-year-old cau-
casian woman presented to the emergency de-
partment with a three-month-history of progres-
sive shortness of breath, left side chest pain and left
side flank pain. She also referred anorexia, 4 Kg
weight loss and malaise in the previous months.
The patient denied nausea, vomiting and diar-
rhoea. She had a past medical history of a strong
cardiovascular disease with a myocardial infarc-
tion, in 2004, four coronary-stents and hyperten-
sion. Her usual medication was: bisoprolol 5mg/
/day; aspirin 100mg/day, pravastatine 40mg/day,
telmisartan plus hydroclorotiazide (40mg + 12.5
mg) and sertraline 50mg/day. On the initial clini-
cal evaluation the patient was in distress, febrile
(38.2ºC), hypotensive (blood pressure was 91/51
mm Hg), the heart rate was 58 beats per min, the
respiratory one was 18 cycles per min and satura-
tion by pulse oximetry O2 was 89% on room air.
Chest auscultation revealed course breathe sounds
bilaterally with no crackles. The cardiac ausculta-
tory examination was unremarkable; specifically,
there were no audible murmurs, gallops, or rubs.
The electrocardiogram (ECG) showed a normal si-
nus rhythm (rate 60 beats per minute) with low-
-vol tage QRS complexes not present in the pre -
viously ECG. Chest radiography presented marked
cardiomegaly. Laboratory data revealed normo-
cytic anaemia, hypoalbuminaemia, elevated ery-
throcyte sedimentation rate (ESR) and C-reactive
protein (CPR) of 9 mg/dl (normal<0.5mg/dl), amy-
lase was normal and myocardial enzymes were ne -
gative. The two-dimensional ecochardiogram de-
tected a large pericardial effusion, but with no dias -
tolic collapse of the right heart chambers. The pa-
tient was admitted in the Coronary Care Unit (CCI),
where she was submitted to a therapeutic pericar-
órgão of ic ial da soc iedade portuguesa de reumatologia - acta reumatol port. 2010;35:160-166
162
chronic periaortitis, pericarditis and pancreatitis
diocentesis. More than 800ml of pericardial fluid
was taken. The laboratory workup of the pericar-
dial exudate was negative for neoplastic cells, my-
cobacterium and other germens. After reaching
cardiac stabilization the patient was transferred to
the Internal Medicine Ward for a further study.
There she was submitted to an abdominal ultra-
sound because of persistent left flank pain. The 
abdominal ultrasound showed dilated calyces and
thickening of the urothelial wall suggesting an in-
flammatory process. Subsequently a scintigraphy
was done, which excluded ureteric obstruction.
Additional laboratory investigation including ANA,
ANCA, and serological testing for Coxsackievirus B
virus, EBV, CMV, Rubella virus, HSV, parvovirus
B19, toxoplasmosis, HIV, hepatitis B and syphilis
were negative. The serum proteinogram was nor-
mal with normal serum IgG4 concentration. A tho-
racic and abdominal CT scan (Figure 1) and MRI
(Figure 2) were done. They revealed a soft tissue
mass embracing the thoracic aorta and spreading
down to the abdominal aorta without any abnor-
mal aorta dilatation (Figures 1 and 2). Both exams
confirmed the thickening of the ureteral wall and
also revealed a hypodense and heterogeneous area
in the tail of the pancreas. A positron emission to-
mography (PET) was undertaken to better charac-
terize the soft tissue surrounding the aorta and the
hypodense area in the tail of the pancreas. This
exam showed the hypermetabolic process em-
bracing the thoracic and abdominal aorta, with the
same metabolic pattern in the body and tail of the
pancreas (Figure 3). This last finding in the pan-
creas was suggestive of an inflammatory process,
which is characteristic in pancreatitis. 
This case was discussed with the surgeons, be-
cause a tissue biopsy was needed not only to con-
firm the diagnosis of a CP, but also to exclude 
other diseases such as neoplasia or infections. Sin -
ce the surgical approach of the pancreas was con-
sidered by the surgeons a complicated procedure,
a percutaneous pericardial and periaortic soft tis-
sue biopsy of the inflammatory mass, using a me-
diastinal window, was done. The histopathology
revealed an inflammatory tissue with a lympho-
plasmocytic infiltration, areas of fibrinoid necro-
sis and small-vessel vasculitis (Figure 4), which
confirmed the diagnosis of chronic periaortitis
confined to the thoracic and abdominal aorta and
idiopathic retroperitoneal fibrosis. The patient be-
gan treatment with an initial dose of 60mg/day of
methylprednisolone and 1mg/day of colchicine.
The β-blocker was stopped. After the first month
treatment a rapid clinical improvement was ob-
served. The 3-month follow-up thoracic and ab-
dominal CT scan showed mild regression in the in-
Fi gu re 1. Computed tomography (CT) scan (axial views). A, B and C (thoracic CT) revealing a non aneurismatical 
form of periaortitis involving the ascending and descending aorta (big arrows). D, E and F (abdominal CT) revealing a
periaortitis of the aorta (big arrows). It also shows a hypodense and heterogeneous area in the tail of the pancreas 
(small arrow-image D) and calyceal dilatation (small arrow-image E).
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Fi gu re 2. Magnetic Resonance imaging (MRI). A and B (thoracic axial view). The T1 (A) and T2 (B) weighted images 
reveal an intermediate intensity signal in the periaortic tissue. Image C (T2 weighted abdominal axial views) reveal 
hyperintense signal in the periaortic tissue (big arrow) and in the tail of the pancreas (small arrow). D, E and F (different
sequences of T1 weighted images axial views) revealing an intermediate signal in the periaortic tissue (big arrow) and an
intermediate and heterogeneous signal in the tail of the pancreas (small arrow). 
Fi gu re 3. F18-Fluordeoxyglucose (FDG) positive emission tomography. Images A, B and C (axial views) showing 
increased tracer uptake in the tissue surrounding the ascending aorta and the abdominal aorta (arrow). There is also an
increased heterogeneous tracer uptake in the body and tail of the pancreas, suggestive of a pancreatitis (arrowhead). 
Image D (coronal and sagittal views) showing increased uptake in the ascending aorta and a segmented uptake in the 
abdominal aorta (big arrow) and in the body of the pancreas suggestive of a pancreatitis (arrowhead). 
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flammatory tissue in the aorta wall, and the evo-
lution into a pseudocyst of the hypodense and he -
terogeneous area in the pancreas (Figure 5). A 
3-month follow-up echocardiogram was also done
and showed no residual pericardial effusion. The
patient has had regular follow-ups and after an 
8-month-treatment she is now on a maintenance
dose of 8mg/day of methylprednisolone and
1mg/day colchicine. 
Discussion
Chronic periaortitis is an uncommon fibro-in-
flammatory disorder of the aorta characterized by
a perivascular fibrotic tissue that may spread into
the retroperitoneum encasing the ureters and 
other structures. This patient had a nonaneurys-
mal form of a chronic periaortitis that extended
caudally from the thoracic to the abdominal aorta
and retroperitoneum. The chronicity of this in-
flammatory process was based not only on the ra-
diologic findings, but also on the constitutional
symptoms, the elevated acute-phase reactant le -
vels and negative serologic tests presented in this
patient for months. The diagnosis of CP and retro -
peritoneal fibrosis was initially suggested based on
the CT, RMN and FDG-PET findings, which were
Fi gu re 4. A. Periaortitis – lymphoid cells and plasma cells invade adventitia (A) and dissociate medial layer (M). Vasa 
vasorum are involved with vasculitis phenomena (arrow). HE X 100. B. Small vessel vasculitis revealed by lymphocytes,
plasma cells and eosinophils in the endothelium. HE X 400 
Fi gu re 5. A. Three months follow-up CT scan of the chronic periaortitis.  A. (Thoracic axial view) regression of 
the periaortic thoracic mass and of the pericardial effusion (arrow). B. (Abdominal axial view) regression of the 
inflammatory periaortic tissue (big arrow) and the evolution into a cyst of the initial hypodense area in the body and 
tail of the pancreas (pancreatitis)(small arrow). 
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done when searching for a neoplasm because of
the initial presentation of a pericarditis with peri-
cardial effusion. The histological analysis of the pe-
riaortic and pericardial tissue confirmed the diag-
nosis of a CP. The FDG-PET revealed the same
metabolic pattern in the periaortic tissue and in the
body and tail of pancreas, which was suggestive of
an inflammatory process, such as pancreatitis.The
3-month follow-up thoracic and abdominal CT
scan revealed a mild regression of the inflamma-
tory tissue embracing the aorta, reduction of the
ureteric wall thickening, resolution of the pericar-
dial effusion and the evolution into a pseudocyst
of the hypodense area in the pancreas. These last
findings supported the hypothesis that the peri-
carditis and the pancreatitis were in relation with
an abnormal extension of the inflammatory pe-
riaortic process. The hypothesis that these fin dings
could be related to the newly recognized IgG4-re-
lated systemic disease was also considered, since
this disorder may manifest as thoracic aortitis or
retroperitoneal fibrosis8. This disorder was first re -
cognized to involve the pancreas as autoimmune
pancreatitis and is now known to involve other or-
gans8,15. Therefore, IgG4 related systemic disease
should always be considered in any patient found
to have periaortitis or retroperitoneal fibrosis.
Since our patient had normal serum IgG4 concen-
tration and no histological features characterized
by the presence of IgG4-expressing plasma cells,
the diagnosis of an IgG4-related periaortitis and
pancreatitis was ruled out. As a biopsy of pan -
creatic hypodense area was not performed, be-
cause of the difficult technical approach, there is
no histological result that could document the
diag nosis of a pancreatitis of possible autoimmune
origin, only the evidence of radiological improve-
ment. The successful medical treatment spared the
patient an unnecessary surgical approach of the
initial hypodense area in the pancreas. 
In this case we didn’t use MRI for the radiologi-
cal follow up, instead we preferred CT, since the risk
(even though the patient didn’t have chronic renal
disease) of developing Gadolinium related Ne -
phro genic Systemic Fibrosis might exist in this pa-
tient with an already inflammatory-fibrosing di -
sea se. The strong cardiovascular background of
this patient sustains the original theory that CP
and IRF are a result of a local reaction to advanced
Atherosclerosis. Though the patient didn’t have any
history suggestive of an underlying autoimmune
disease, the histological findings, such as lympho-
plasmocytic infiltration, suggestive of small-ves-
sel vasculitis support the hypothesis that CP is re-
lated to an inflammatory/autoimmune systemic
disease. Currently, there is no standardized treat-
ment for CP and IRF. Therapeutic options vary from
steroids to other immunosuppressive drugs. The
promising results of some studies25 prompted the
initiation of methylprednisolone and colchicine in
this patient. Other effective treatments options
were available, such as tamoxifen with less long-
-term hazardous side-effects23. However, because
of the clear clinical and radiological improvement,
the patient is being maintained on the same treat-
ment with steroids (with slower reduction in the
dose) and colchicine.
This case report illustrates the importance of
the awareness and recognition of imaging findings
that are crucial for an early diagnosis and institu-
tion of adequate therapy. It is also an example of
an atypical presentation of a CP and IRF and calls
attention for the rare association with a pericardi-
tis and a pancreatitis. 
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